Rakesh K. Srivastava

University Of Texas Hlth Ctr At Tyler

$4,102,428

Attributed

$4,102,428

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1M · FY2008–25

$2M$1.5M$1M$500K$0

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$4,102,428 · 5

By mechanism

R01$2,614,394 · 3

R44$1,378,034 · 1

R03$110,000 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Texas Hlth Ctr At Tyler

Same institution · by research overlap

Sharmila Shankar$138,392

Others in their field

Top investigators on “In Vivo”

David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
Dennis R. Burton · Scripps Research Institute$212,708,174
Mark S Klempner · Tufts Medical Center$128,021,180
Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200

Research focus

In VivoMolecularTumor GrowthTranscription FactorNeoplasm MetastasisCancer EtiologyIn VitroGenesGrowthPathway InteractionsGene TargetingBaseMediatingEventMalignant Neoplasm Of PancreasResistanceTumor InitiationPancreasPlayDuctal Epithelial CellApoptosisIncidenceSurvival RateXenograft Procedure